ADC Therapeutics
ADCT
ADCT
36 hedge funds and large institutions have $156M invested in ADC Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
3% less funds holding
Funds holding: 37 → 36 (-1)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
Holders
36
Holding in Top 10
3
Calls
$902K
Puts
$305K
Top Buyers
| 1 | +$5.19M | |
| 2 | +$4.49M | |
| 3 | +$2.6M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$2.25M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$2.25M |
Top Sellers
| 1 | -$7.46M | |
| 2 | -$4.05M | |
| 3 | -$1.68M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.49M |
| 5 |
Jane Street
New York
|
-$333K |